Wealth Enhancement Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 279,772 shares of GILD stock, worth $31.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
279,772
Previous 324,469
13.78%
Holding current value
$31.3 Million
Previous $30 Million
13.78%
% of portfolio
0.05%
Previous 0.06%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
2,110Shares Held
989MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.03 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.77 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.49 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...